Company: IONQ
Filing Date: 2025-09-17
Form Type: 8-K
Source: 0001193125-25-205489
Chunk: 2

Company: IonQ, Inc.
Filing Date: 2025-09-17
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01      Other Events.  

On September 16, 2025, the Company completed its previously announced transaction (the “ Oxford Ionics Transaction”) to acquire all of the issued and outstanding shares of Oxford Ionics Limited, a private limited company incorporated in England and Wales (“ Oxford Ionics”), pursuant to the terms of the Share Purchase Agreement, dated June 7, 2025 (the “ Agreement”), among the Company, Oxford Ionics, the Sellers (as defined in the Agreement), and Oxford Science Enterprises plc, solely in its capacity as the representative of the Sellers. The aggregate consideration delivered at the closing of the Oxford Ionics Transaction consisted of 26,622,077 shares of the Company’s common stock (the “ Stock Consideration”) and $10,000,000 in cash.

In connection with the closing of the Oxford Ionics Transaction and in connection with the issuance of the Stock Consideration, the Company and Oxford Science Enterprises plc, solely in its capacity as the representative of the Sellers (the “ Securityholders”), entered into a Registration Rights Agreement, dated September 16, 2025 (the “ Registration Rights Agreement”), pursuant to which the Securityholders will have certain registration rights relating to the Stock Consideration.

The foregoing description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such Registration Rights Agreement, a copy of which is filed herewith as Exhibit 10.1 to this Current Report on Form8-Kand is incorporated by reference herein.

In addition, on September 16, 2025, the Company entered into a definitive agreement to acquire Vector Atomic, Inc. in an all-stocktransaction (the “ Vector Atomic Transaction”) for 6,294,058 shares of the Company’s common stock, subject to the terms and conditions of the definitive agreement and customary purchase price adjustments. The Vector Atomic Transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.

  Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits

  Exhibit      Description                                                                                                                   
      No.                                                                                                                                    
     10.1      Registration Rights Agreement, dated as of September 16, 2025, by and between IonQ, Inc. and Oxford Science Enterprises plc.  
     99.1      Press Release announcing the closing of the Oxford Ionics Transaction, dated September 17, 2025.                              
     99.2      Press Release announcing the entry